¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Systemic Fungal Infection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • laboratory infection control
    °Ë»ç½Ç°¨¿°°ü¸®
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ¼º°¨¿°
  • lytic infection
    ¿ë±Õ°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
  • milk-borne infection
    ¿ìÀ¯¸Å°³°¨¿°
  • mixed infection
    È¥ÇÕ°¨¿°
  • mock infection
    ¸ðÀǰ¨¿°½ÇÇè
  • multiple infection
    º¹¼ö°¨¿°, ¿©·¯¹ø°¨¿°
  • mycotic infection
    °õÆÎÀ̰¨¿°, Áø±Õ°¨¿°
  • mass infection
    Áý´Ü°¨¿°
  • neonatal infection
    ½Å»ý¾Æ°¨¿°
  • nosocomial infection
    º´¿ø³»°¨¿°
  • nosocomial infection control
    º´¿ø³»°¨¿°°ü¸®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • insect-borne infection
    °ïÃæ¸Å°³°¨¿°
  • intercurrent infection
    º´¹ß°¨¿°
  • introduced infection
    µµÀÔ°¨¿°
  • latent infection
    Àẹ°¨¿°
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ°¨¿°
  • lytic infection
    ¿ë±Õ¼º°¨¿°
  • mass infection
    Áý´Ü°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
  • milk-borne infection
    ¿ìÀ¯¸Å°³°¨¿°
  • mixed infection
    È¥ÇÕ°¨¿°
  • mock infection
    ¸ðÀǰ¨¿°½ÇÇè
  • multiple infection
    ¿©·¯¹ø°¨¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • huma immunodeficiency virus,follicular dendritic cell infection by
    ¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
  • inapparant infection
    ºÒÇö°¨¿°
  • inapparent infection
    ºÒÇö¼º °¨¿°.
  • indirect contact infection
    °£Á¢Á¢Ã˰¨¿° <Àü¿°>.
  • indirect infection
    °£Á¢°¨¿°.
  • infection
    °¨¿°(Êïæø), Àü¿°(îîæø).
  • infection
    °¨¿°
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • infection by dirt
    ¿À¹°°¨¿°(çýÚªÊïæø).
  • infection control study
    °¨¿°°ü¸®¿¬±¸
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • infection cycle
    °¨¿°»ç, °¨¿°È¯
  • infection focus
    °¨¿°¼Ò(Êïæøáµ).
  • infection immunity
    °¨¿°¸é¿ª.
  • infection route
    °¨¿°°æ·Î.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • systemic nodular periarteritis
    Àü½Å °áÀý µ¿¸Æ ÁÖÀ§¿°
  • systemic reaction
    Àü½Å¹ÝÀÀ(îïãóÚãëë).
  • systemic reaction
    Àü½Å¹ÝÀÀ(îïãóÚãëë)
  • systemic scleroderma
    Àü½Å¼º °æÇÇÁõ(¡­Ìã ù«ñø)
  • systemic sclerosis
    Àü½Å¼º °æÈ­(Áõ)
  • systemic sclerosis [=scleroderma]
    Àü½Å¼º°æÈ­Áõ[= °æÇÇÁõ]
  • systemic therapy
    Àü½Å Ä¡·á
  • systemic treatment
    Àü½Å¿ä¹ý(îïãóèþÛö).
  • abnormality by infection
    °¨¿°±âÇü
  • abortive infection
    ºÒÇö¼º°¨¿°(ÝÕúéàõÊïæø).
  • abortive infection
    ºÒ¹ß°¨¿°, ºÎÀü°¨¿°
  • adenovirus infection
    ¾Æµ¥³ë¹ÙÀÌ·¯½º°¨¿°.
  • aerial infection = airborne i.
    °ø±â°¨¿°(ÍöѨÊïæø)
  • aerial infection =air borne i.
    °ø±â°¨¿°(ÍöѨÊïæø), ÈíÀÔ°¨¿°(ýåìýÊïæø).
  • aerobic infection
    È£±â±Õ(¼º) °¨¿°(¡­Êïæø).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
SBP schizobipolar; serotonin-binding protein; spontaneous bacterial peritonitis; steroid-binding plasma ...
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
SCBH systemic cutaneous basophil hypersensitivity
SCD scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu...
SCLS systemic capillary leak syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
SMCD Systemic mast cell disease
SM Systemic mastocytosis
SR Systemic reactions
SSc Systemic scleroderma
SSd Systemic scleroderma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pulmonary infection
    Æó °¨¿°
  • pyogenic infection
    È­³ó¼º °¨¿°
  • recurrent herpes simplex virus infection
    Àç¹ß¼º ´Ü¼ø Æ÷Áø ¹ÙÀÌ·¯½º °¨¿°
  • route of infection
    °¨¿° °æ·Î
  • salmonella infection
    »ì¸ð³Ú¶ó °¨¿°Áõ
  • septic infection
    ÆÐÇ÷¼º °¨¿°, ÆÐÇ÷Áõ¼º °¨¿°
  • Serratia infection
    ¼¿¶óƼ¾Æ °¨¿°Áõ
    ·¹À̱ÕÀ̶ó°í ÇÏ´Â ¼ÒÇüÀÇ ±×¶÷ À½¼º °£±Õ¿¡ ÀÇÇØ ÀϾ°í, ±âÃÊ ÁúȯÀ» °¡Áö´Â ȯÀÚÀÇ Á¾¸» °¨¿°À¸·Î¼­ º´¿ø¼ºÀ» ¹ßÇÑ´Ù.
  • slow virus infection
    ½½·Î¿ì ¹ÙÀÌ·¯½º °¨¿°
  • source of infection
    °¨¿°¿ø
  • staphylococcal infection
    Æ÷µµ»ó ±¸±Õ °¨¿°
  • upper respiratory infection
    »ó±âµµ °¨¿°
  • virus respiratory infection
    ¹ÙÀÌ·¯½º¼º È£Èí±â °¨¿°Áõ
  • water borne infection
    ¼öÀμº °¨¿°
  • water-borne infection
    ¼öÀμº °¨¿°, ¼öÀμº Àü¿°
  • waterborne infection
    ¼öÀμº Àü¿°º´
    ¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
Salinem infection Infection with Leptospira pyrogenes, reported in Salinem.
Synonym: Salinem infection.
(05 Mar 2000)
scalp infection An infection external to the galea; e.g., folliculitis or cellulitis.
(05 Mar 2000)
screw worm infection Infection with larvae of the blow fly cochliomyia hominivorax (callitroga americanum), a common cause of disease in livestock in the southern and southwestern u.s.a.
(12 Dec 1998)
secondary infection An infection, usually septic, occurring in a person or animal already suffering from an infection of another nature.
(05 Mar 2000)
puerperal infection An infection occurring in the puerperium or postpartum period.
(12 Dec 1998)
self-infection 1. Reinfection by microbes or parasitic organisms on or within the body that have already passed through an infective cycle, such as a succession of boils, or a new infective cycle with production of a new generation of larvae and adults, as by the nematode Strongyloides stercoralis or the cestode Hymenolepsis nana.
2. Self-infection by direct contagion as with parasite eggs passed in the infectious state transmitted by fingernails (anal-oral route), as with the pinworm, Enterobius vermicularis.
Synonym: autoreinfection, self-infection.
(05 Mar 2000)
pyogenic infection Infection characterised by severe local inflammation, usually with pus formation, generally caused by one of the pyogenic bacteria.
(05 Mar 2000)
natural focus of infection An ecosystem in which an infectious agent normally persists in nature; e.g., yellow fever virus in a jungle monkey-Haemagogus mosquito ecosystem.
(05 Mar 2000)
subclinical infection <epidemiology> An infection in which symptoms are sufficiently mild or inapparent to escape diagnosis other than by positive confirmation of the ability to transmit the infection or serologically.
(05 Dec 1998)
nosocomial infection <microbiology> Hospital acquired infection: commonest are due to Staphylococcus aureus, Pseudomonas aeruginosa, E. Coli, Klebsiella pneumoniae, Serratia marcescens and Proteus mirabilis.
(18 Nov 1997)
surgical wound infection Infection occurring at the site of a surgical incision.
(12 Dec 1998)
disseminated gonococcal infection Infection from Neisseria gonorrhoea which is spread to distant parts of the body beyond the original portal of entry (usually the lower genital tract). Usually manifest by rash and arthritis.
(05 Mar 2000)
droplet infection Infection acquired through the inhalation of droplets or aerosols of saliva or sputum containing virus or other microorganisms expelled by another person during sneezing, coughing, laughing, or talking.
(05 Mar 2000)
inapparent infection Presence of infection in a host without the occurrence of recognizable symptoms or signs.
(05 Mar 2000)
infection 1. <microbiology> Invasion and multiplication of microorganisms in body tissues, which may be clinically unapparent or result in local cellular injury due to competitive metabolism, toxins, intracellular replication or antigen antibody response. The infection may remain localised, subclinical and temporary if the bodys defensive mechanisms are effective. A local infection may persist and spread by extension to become an acute, subacute or chronic clinical infection or disease state. A local infection may also become systemic when the microorganisms gain access to the lymphatic or vascular system.
2. An infectious disease.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á